Daily Archives: April 2, 2024, 7:56 am

Former Federal Prosecutor and Tech GC Joins Boies Schiller Flexner as Partner

Boies Schiller Flexner LLP today announced that Nili Moghaddam has joined as a partner, splitting her time between the firm’s Los Angeles and San Francisco offices. Nili brings a diverse skill set to the firm, focusing on corporate litigation, white collar defense, and trial work. Nili has spent the past five years in increasingly senior in-house roles at digital tech…

Read More

Holland & Knight Strengthens Litigation Practice with Addition of John Grugan in Philadelphia | Holland & Knight

Holland & Knight has added veteran litigator John Grugan as a partner in Philadelphia. Prior to joining Holland & Knight, he was a partner at Ballard Spahr. Mr. Grugan represents clients in government investigations and complex litigation brought by the U.S. Securities and Exchange Commission (SEC), U.S. Department of Justice (DOJ), Consumer Financial Protection Bureau (CFPB) and state attorneys general.…

Read More

Bitcoin Is Soaring This Year. This Goldman Sachs Skeptic Isn’t Biting. – WSJ

… Wall Street giants including BlackRock and Fidelity have embraced bitcoin, launching funds in January that make it easy for everyday investors to invest in it. Some financial advisers have also begun advising clients to include crypto in their portfolios. Mossavar-Rahmani couldn’t care less what the others do. “We do not think it is an investment asset class,” she said…

Read More

Bitcoin’s Future as Currency

The ETFs miss the point, though. Bitcoin is not an asset to hold; it is a currency to use. Bitcoin doesn’t have a price, it has an exchange rate. The future of bitcoin is not that of an asset sitting in an ETF or buried in one’s backyard in a hardware wallet. Currencies are meant to transact. *** For this…

Read More

Life Sciences Companies Remained Frequent Securities Suit Targets in 2023 | The D&O Diary

The number of securities class action lawsuits filed against life sciences companies in 2023 remained steady compared to 2022, as suits against life sciences companies represented almost one in five of the securities class action lawsuits filed during the year, according to a new report from the Dechert law firm. The report, entitled “Dechert Survey: Developments in Securities Fraud Class…

Read More